160 related articles for article (PubMed ID: 30761579)
1. A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers.
Xie F; Vermeulen A; Colin P; Cheng Z
Br J Clin Pharmacol; 2019 May; 85(5):1003-1014. PubMed ID: 30761579
[TBL] [Abstract][Full Text] [Related]
2. Inter- and Intra-individual Variability in the Pharmacokinetics of Agomelatine Tablets in Chinese Healthy Male Subjects.
Wang XL; Du AH; Zhang D; Meng LJ; Liu M; Zhang LN; Zhao HN; Liu HC
Drug Res (Stuttg); 2015 Oct; 65(10):552-4. PubMed ID: 25383559
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.
Li C; Xu J; Zheng Y; Chen G; Wang J; Ma L; Qiao Y; Niu J; Wu M; Zhang H; Li X; Chen H; Zhu X; Liu C; Ding Y
Chem Pharm Bull (Tokyo); 2017 Jun; 65(6):524-529. PubMed ID: 28392509
[TBL] [Abstract][Full Text] [Related]
4. Effect of CYP1A2 polymorphism on the pharmacokinetics of agomelatine in Chinese healthy male volunteers.
Song L; Du Q; Jiang X; Wang L
J Clin Pharm Ther; 2014 Apr; 39(2):204-9. PubMed ID: 24372004
[TBL] [Abstract][Full Text] [Related]
5. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.
Fatouh AM; Elshafeey AH; Abdelbary A
Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900
[TBL] [Abstract][Full Text] [Related]
6. Agomelatine treatment of major depressive disorder.
Dolder CR; Nelson M; Snider M
Ann Pharmacother; 2008 Dec; 42(12):1822-31. PubMed ID: 19033480
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the highly variable agomelatine pharmacokinetics in Chinese healthy subjects to support bioequivalence study.
Pei Q; Wang Y; Hu ZY; Liu SK; Tan HY; Guo CX; Zhang RR; Xiang YX; Huang J; Huang L; Yuan H; Yang GP
PLoS One; 2014; 9(10):e109300. PubMed ID: 25330096
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Belmonte C; Román M; Vieira de Lara D; Zubiaur P; Koller D; Mejía G; Abad-Santos F
J Psychopharmacol; 2019 Apr; 33(4):522-531. PubMed ID: 30789308
[TBL] [Abstract][Full Text] [Related]
9. Development and validation a LC-MS/MS method for the simultaneous determination of agomelatine and its metabolites, 7-desmethyl-agomelatine and 3-hydroxy-agomelatine in human plasma: Application to a bioequivalence study.
Li M; Tang F; Xie F; Lv Y; Yu P; Liu Z; Cheng Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():60-6. PubMed ID: 26409931
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers.
Zhang F; Li Y; Hu J; Zhong J; Li H
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):339-352. PubMed ID: 30520001
[TBL] [Abstract][Full Text] [Related]
11. Agomelatine: A novel melatonergic antidepressant. Method validation and first exploratory pharmacokinetic study in fasted and fed dogs.
Łebkowska-Wieruszewska B; Ziółkowski H; Sartini I; Lisowski A; Kowalski CJ; Poapolathep A; Giorgi M
Res Vet Sci; 2021 Oct; 139():140-144. PubMed ID: 34303122
[TBL] [Abstract][Full Text] [Related]
12. The use of antidepressants in clinical practice: focus on agomelatine.
McAllister-Williams RH; Baldwin DS; Haddad PM; Bazire S
Hum Psychopharmacol; 2010 Mar; 25(2):95-102. PubMed ID: 20196187
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects.
Li S; Xu M; Li H; Du J; Li W
Adv Ther; 2016 Oct; 33(10):1704-1714. PubMed ID: 27444313
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.
Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
[TBL] [Abstract][Full Text] [Related]
16. Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay.
Chen B; Xu Y; Jiang T; Feng R; Sun J; Zhang W; Yang W; Li J; Adeniyi O; Chen H
J Clin Pharm Ther; 2013 Dec; 38(6):504-11. PubMed ID: 23981149
[TBL] [Abstract][Full Text] [Related]
17. Effects of depression and melatonergic antidepressant treatment alone and in combination with sedative-hypnotics on heart rate variability: Implications for cardiovascular risk.
Chang CC; Tzeng NS; Yeh CB; Kuo TBJ; Huang SY; Chang HA
World J Biol Psychiatry; 2018 Aug; 19(5):368-378. PubMed ID: 28281386
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
[TBL] [Abstract][Full Text] [Related]
20. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
